Chronic Kidney Disease (CKD)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Need for the placement of AVF before the initiation of dialysis therapy 2) Confirmation of informed consent
Exclusion criteria
Exclusion criteria: 1) Change in the antihypertensive medication one month before enrollment 2) Vasopressin antagonists 3) Endocrine hypertension 4) Accelerated o r malignant hypertension (progressive renal dysfunction with diastolic BP of >120-130 mmHg 5) Nephrotic syndrome (serum albumin <2.5 g/dl) 6) Serious conditions with congestive heart failure, coronary diseases, arrhythmia or systemic diseases 7) Implantation of a pacemaker 8) During pregnancy 9) Any reason for ineligibility suggested by the attending doctor (usage of beta-blockers)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cadiac output,circadian BP rhythm, and urinary sodium excretion | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) heart rate variability (non-Gaussianity INDEX, , SDNN, VLF, HF, LF/HF, Alfa1, DC, HRT, HRVTI) 2) catecholamine 3) PRA, PAC, AI, AII, Urinary AGT 4) hANP, BNP 5) ADH, free water clearance | — |
Countries
Japan
Contacts
Nagoya City University Hospital Division of Nephrology